IMDX · NASDAQ · Medical - Diagnostics & Research

Insight Molecular Diagnostics

Develops molecular diagnostic tests for transplant rejection and oncology therapy programs.

$4.13
After-hours close0.00 (0.00%)
At close$4.13(−3.73%)
DateEstimateReportedSurprise
Nov 2026−$0.23
Aug 2026−$0.25−$0.31−22.1%
May 2026−$0.26−$0.28−7.1%
Mar 2026−$0.24−$0.27−13.7%
Nov 2025−$0.24−$0.34−41.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Jul 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Apr 2019
Nov 2018
Aug 2018
May 2018
Apr 2018
Nov 2017
Aug 2017
Apr 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 9, 2026−$0.23$215.1K
Aug 10, 2026−$0.25−$0.31−22.1%$352.5K$239.0K−32.2%
May 13, 2026−$0.26−$0.28−7.1%$229.2K$32.0K−86.0%
Mar 26, 2026−$0.24−$0.27−13.7%$285.0K$1.1M+299.6%
Nov 10, 2025−$0.24−$0.34−41.7%$285.0K$260.0K−8.8%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 11, 2025
May 12, 2025
Mar 24, 2025
Nov 12, 2024
Aug 8, 2024
May 15, 2024
Mar 29, 2024
Nov 9, 2023
Aug 10, 2023
May 11, 2023
Mar 29, 2023
Nov 10, 2022
Aug 10, 2022
May 11, 2022
Mar 10, 2022
Nov 9, 2021
Aug 10, 2021
May 17, 2021
Mar 16, 2021
Nov 12, 2020
Jul 29, 2020
May 12, 2020
Mar 25, 2020
Nov 14, 2019
Aug 14, 2019
May 14, 2019
Apr 1, 2019
Nov 13, 2018
Aug 14, 2018
May 15, 2018
Apr 2, 2018
Nov 14, 2017
Aug 14, 2017
Apr 28, 2017
Feb 27, 2017
Nov 10, 2016
Aug 11, 2016
May 16, 2016
Mar 30, 2016
Nov 16, 2015
Aug 14, 2015